The clinical use of β-receptor agonists; for and against
- 31 December 1993
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 52 (26) , 2171-2179
- https://doi.org/10.1016/0024-3205(93)90731-h
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Asthma mortality and inhaled beta agonist therapyAustralian and New Zealand Journal of Medicine, 1991
- Beta agonists and asthma mortality: déjà vuClinical and Experimental Allergy, 1991
- Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study.Thorax, 1991
- Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthmaThe Lancet, 1990
- The pulmonary and extrapulmonary effects of inhaled β-agonists in patients with asthmaClinical Pharmacology & Therapeutics, 1990
- Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81.Thorax, 1990
- The cardiovascular effects of beta adrenergic agonist drugs administered by nebulisationPostgraduate Medical Journal, 1990
- PRESCRIBED FENOTEROL AND DEATH FROM ASTHMA IN NEW ZEALAND, 1981-83; CASE-CONTROL STUDYThe Lancet, 1989
- Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline.Thorax, 1989
- International Trends in Asthma Mortality: 1970 to 1985Chest, 1988